The Pottstown Mercury reports today that pharmaceutical company Sanofi Aventis, based in France, will close its Great Valley, Pennsylvania research and development site by July 2011. The Mercury says Sanofi Aventis will keep clinical supply and related support activities at the Great Valley site.
Elizabeth Baxter, a spokesperson for Sanofi Aventis, told the Mercury that the company plans to offer 303 Great Valley employees positions in other research facilities in Bridgewater, New Jersey and Cambridge, Massachusetts. Some 45 workers will remain to handle the clinical supply work, but 105 of the current staff will be laid off.
Related: Sanofi-aventis, Scripps to Partner on Personalized Medicines
Hat tip: Fierce Biotech
RSS - Posts